title: Influenza vaccine safety in children less than 5 years old: the 2010 and 2011 experience in Australia.
abstract: In August 2010, the United States Advisory Committee on Immunization Practices recommended that the 2010-2011 CSL seasonal vaccine (Afluria) not be administered to children 6 months to 8 years of age because of the risk of febrile convulsion after immunization. This study reports a low rate (6%-7%) of fever after immunization with 2 non-CSL brands of 2011 seasonal influenza vaccine in Australian children <5 years of age. These data are reassuring for parents and healthcare workers regarding 2011 influenza vaccination in the northern hemisphere.
authors.affiliation: National Centre for Immunisation Research and Surveillance of Vaccine-Preventable Diseases, New South Wales, Australia. nicholw3@chw.edu.au
authors.forename: Nicholas
authors.initials: N
authors.lastname: Wood
authors.forename: Vicky
authors.initials: V
authors.lastname: Sheppeard
authors.forename: Patrick
authors.initials: P
authors.lastname: Cashman
authors.forename: Pamela
authors.initials: P
authors.lastname: Palasanthiran
authors.forename: Margot
authors.initials: M
authors.lastname: Casacelli
authors.forename: Kathryn
authors.initials: K
authors.lastname: Cannings
authors.forename: Peter
authors.initials: P
authors.lastname: McIntyre
mesh_terms: D001315:Australia; D002675:Child, Preschool; D005260:Female; D005334:Fever / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007223:Infant; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male
chemical_list: D007252:Influenza Vaccines